Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -15821.11x is 149% below its 5-year average of -6359.54x, near the low end of its 5-year range (-19217.34x–-6.29x).
As of the fiscal period ended Tuesday, March 31, 2015. 3.88% below its 12-month average of -15229.97x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2015 (2015-03-31): -15821.11x.
INTEREST COVERAGE RATIO
-15821.11x
INTEREST COVERAGE RATIO AVG TTM
-15229.97x
INTEREST COVERAGE RATIO AVG 3Y
-15229.97x
INTEREST COVERAGE RATIO AVG 5Y
-6359.54x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.88%
CURRENT VS 3Y AVG
-3.88%
CURRENT VS 5Y AVG
-148.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 454 covered companies
CURRENT VS SECTOR MEDIAN
-280416.08%
vs the sector median at left
MediciNova, Inc.
Market Cap
$82.45M
Interest Coverage Ratio
-15821.11x
TTM Avg
-15229.97x
3Y Avg
-15229.97x
5Y Avg
-6359.54x
Market Cap
$82.28M
Interest Coverage Ratio
-107.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$80.59M
Interest Coverage Ratio
-369.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.98M
Interest Coverage Ratio
-3676.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.93M
Interest Coverage Ratio
-17.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediciNova, Inc. (MNOV) | $82.45M | -15821.11x | -15229.97x | -15229.97x | -6359.54x |
| LENSAR Inc (LNSR)vs › | $82.16M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $82.28M | -107.89x | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $80.59M | -369.11x | N/A | N/A | N/A |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.48M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.98M | -3676.85x | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.60M | -9.55x | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $79.93M | -17.01x | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $84.40M | N/A | 26.56x | 26.56x | 26.56x |
Interest Coverage
-15821.1x
Debt/Equity
0.00
Current Ratio
8.75
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2015-03-31 | -15821.11x |
| 2014-12-31 | -15781.30x |
| 2014-09-30 | -13556.41x |
| 2014-06-30 | -11773.71x |
| 2014-03-31 | -19217.34x |
| 2011-12-31 | -7.11x |
| 2011-06-30 | -8.27x |
| 2011-03-31 | -7.63x |
| 2010-12-31 | -6.60x |
| 2010-09-30 | -6.29x |
| 2010-06-30 | -10.22x |
| 2010-03-31 | -118.54x |
| 2009-09-30 | -77.25x |
| 2009-06-30 | -75.93x |
